NDC 0409-9094

Fentanyl Citrate

Fentanyl Citrate

Fentanyl Citrate is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Fentanyl Citrate.

Product ID0409-9094_060afea1-70bf-4295-82ff-0fbd65b819c8
NDC0409-9094
Product TypeHuman Prescription Drug
Proprietary NameFentanyl Citrate
Generic NameFentanyl Citrate
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2005-09-27
Marketing CategoryNDA / NDA
Application NumberNDA019115
Labeler NameHospira, Inc.
Substance NameFENTANYL CITRATE
Active Ingredient Strength50 ug/mL
Pharm ClassesFull Opioid Agonists [MoA],Opioid Agonist [EPC]
DEA ScheduleCII
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0409-9094-22

25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9094-22) > 2 mL in 1 VIAL, SINGLE-DOSE (0409-9094-12)
Marketing Start Date2010-12-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0409-9094-22 [00409909422]

FENTANYL CITRATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019115
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2010-12-02

NDC 0409-9094-12 [00409909412]

FENTANYL CITRATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019115
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-02-24

NDC 0409-9094-18 [00409909418]

FENTANYL CITRATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019115
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-02-24

NDC 0409-9094-17 [00409909417]

FENTANYL CITRATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019115
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-02-24

NDC 0409-9094-28 [00409909428]

FENTANYL CITRATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019115
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2006-02-17

NDC 0409-9094-16 [00409909416]

FENTANYL CITRATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019115
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-02-24

NDC 0409-9094-25 [00409909425]

FENTANYL CITRATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019115
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-11-09

NDC 0409-9094-09 [00409909409]

FENTANYL CITRATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019115
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-12-06
Marketing End Date2020-11-01

NDC 0409-9094-31 [00409909431]

FENTANYL CITRATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019115
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-09-27

NDC 0409-9094-11 [00409909411]

FENTANYL CITRATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019115
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-12-06
Marketing End Date2020-11-01

NDC 0409-9094-41 [00409909441]

FENTANYL CITRATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019115
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-02-24

NDC 0409-9094-61 [00409909461]

FENTANYL CITRATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019115
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-12-22

Drug Details

Active Ingredients

IngredientStrength
FENTANYL CITRATE50 ug/mL

OpenFDA Data

SPL SET ID:bfa8018a-4cbc-434b-e09e-782872b0340a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1735007
  • 1735006
  • 1735013
  • 1735003
  • 1735008

    • Pharmacological Class

    • Full Opioid Agonists [MoA]
    • Opioid Agonist [EPC]

    NDC Crossover Matching brand name "Fentanyl Citrate" or generic name "Fentanyl Citrate"

    NDCBrand NameGeneric Name
    0093-7865Fentanyl CitrateFentanyl Citrate
    0093-7866Fentanyl CitrateFentanyl Citrate
    0093-7867Fentanyl CitrateFentanyl Citrate
    0093-7868Fentanyl CitrateFentanyl Citrate
    0093-7869Fentanyl CitrateFentanyl Citrate
    0093-7870Fentanyl CitrateFentanyl Citrate
    0406-9202FENTANYL CITRATEFENTANYL CITRATE
    0409-9093FENTANYL CITRATEFENTANYL CITRATE
    0409-9094Fentanyl CitrateFentanyl Citrate
    0641-6024Fentanyl CitrateFentanyl Citrate
    0641-6026Fentanyl CitrateFentanyl Citrate
    0641-6028Fentanyl CitrateFentanyl Citrate
    0641-6029Fentanyl CitrateFentanyl Citrate
    0641-6030Fentanyl CitrateFentanyl Citrate
    0641-6025Fentanyl CitrateFentanyl Citrate
    0641-6027Fentanyl CitrateFentanyl Citrate
    17478-030FENTANYL CITRATEFENTANYL CITRATE
    17478-031FENTANYL CITRATEFENTANYL CITRATE
    52533-074Fentanyl CitrateFentanyl Citrate
    52533-025Fentanyl CitrateFentanyl Citrate
    52533-214FENTANYL CITRATEFENTANYL CITRATE
    0406-9216FENTANYL CITRATEFENTANYL CITRATE
    0406-9204FENTANYL CITRATEFENTANYL CITRATE
    0406-9206FENTANYL CITRATEFENTANYL CITRATE
    0406-9208FENTANYL CITRATEFENTANYL CITRATE
    0406-9212FENTANYL CITRATEFENTANYL CITRATE
    0409-1276Fentanyl CitrateFentanyl Citrate
    63323-806Fentanyl CitrateFentanyl Citrate
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.